CIT-Logo-White Created with Sketch.

MENU
Device Guides
Trial Guide
Centers
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

Building an Efficient TAVR Program

By Sandeep M. Patel, MD; J. Brandon Elmore, MD; Edwin G. Avery, MD; Marco A. Costa, MD, PhD; Alan Markowitz, MD; Angela Davis, RN; and Guilherme F. Attizzani, MD; on behalf of The Valve Structural Heart Disease Intervention Center, Harrington Heart and Vascular Institute, Cleveland, OH

cit | Article | September/October 2013

Percutaneous Pulmonary Valve Replacement

Indications, current practice, and the ongoing evolution of this technique.

By Damien Kenny, MB, MD; Qi-Ling Cao, MD; and Ziyad M. Hijazi, MD, MPH, FSCAI

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

TAVR Optimization Using Best Practices

By Mathew Williams, MD; Michael Querijero, MSPA; and Tara Collins, MSPA; on behalf of New York University Langone Medical Center, New York, NY

cit | News | October 24, 2024

CroíValve Begins TANDEM II Early Feasibility Study for Duo System to Treat TR

October 24, 2024—CroíValve announced the first patient treated with the Duo system as part of the TANDEM II early feasibility study in the United States.

Advertisement

cit | News | December 2, 2022

Peijia Medical and inQB8 Medical Report FIH Implantation of MonarQ TTVR System

December 2, 2022—inQB8 Medical Technologies, LLC, in partnership with Peijia Medical Limited, recently announced a successful transcatheter tricuspid valve replacement (TTVR) procedure with the MonarQ transcatheter tricuspid valve (TTV) in a 75-year-old female with severe torrential tricuspid regurgitation.

cit | News | June 26, 2019

SCAI Supports CMS Decision Memo on Procedural Requirements for TAVR

June 27, 2019—The Society for Cardiovascular Angiography and Interventions (SCAI) released a statement regarding the Centers for Medicare & Medicaid Services (CMS) finalized Decision Memo on Transcatheter Aortic Valve Replacement (TAVR) released on June 21.

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

TAVR Economics in a Community Program

By Hemal Gada, MD, MBA, and Mubashir Mumtaz, MD, FACS, FACC, on behalf of PinnacleHealth CardioVascular Institute, Harrisburg, PA

cit | News | June 26, 2011

ACC and STS Issue Expert Consensus Document on Transcatheter Valve Therapy

June 27, 2011—The American College of Cardiology (ACC) and the Society of Thoracic Surgeons (STS) have published an expert consensus document on transcatheter valve therapy.

cit | News | June 19, 2023

Hangzhou Valgen’s DRAGONFLY-DMR Pivotal Trial Results Presented

June 19, 2023—China-based Hangzhou Valgen Medtech Co., Ltd. announced the 12-month results of the DRAGONFLY-DMR pivotal trial evaluating the safety and efficacy of transcatheter-edge-to-edge repair (TEER) with the company’s DragonFly valve repair system.

Advertisement

Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button